# OnCo record nicola-gokbuget (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/nicola-gokbuget/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "nicola-gokbuget" ;
  schema:name "Nicola Gökbuget"@en ;
  schema:description "Leads the German GMALL group and showed blinatumomab clears residual leukaemia in adults with ALL."@en ;
  schema:url <https://onco.cc/people/nicola-gokbuget/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Gokbuget%20N%5BAuthor%5D%20acute%20lymphoblastic%20leukemia> ;
  onco:tag "all", "mrd", "cooperative-group" ;
  schema:jobTitle "Head of the GMALL Study Group; Professor of Medicine, University Hospital Frankfurt" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/> ;
  onco:institutions <https://onco.cc/institutions/uct-frankfurt/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-e1910-blinatumomab-mrd-negative-all-nejm-2024/> ;
  schema:affiliation <https://onco.cc/institutions/uct-frankfurt/> .